Thursday March 28, 2024 | Last Update: March 28, 2024 EDT
Mallinckrodt Plc, has entered into a “definitive agreement” with The Gores Group LLC for a subsidiary of Mallinckrodt to acquire Therakos, Inc., a leading immunotherapy company, for approximately $1.325 billion, according to press release issued by Mallinckrodt.
Read more >>
Just In
Most Read
1
2